BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36215396)

  • 1. Predicting Treatment Response in Primary Aldosteronism Using 11 C-Metomidate Positron Emission Tomography.
    Lu CC; Chen CJ; Peng KY; Chueh JS; Chang CC; Yen RF; Wu VC;
    Clin Nucl Med; 2022 Nov; 47(11):936-942. PubMed ID: 36215396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lateralization in
    Isojärvi J; Viukari M; Pörsti I; Leijon H; Vesterinen T; Seppänen M; Nevalainen PI; Matikainen N
    Endocrinol Diabetes Metab; 2022 Nov; 5(6):e368. PubMed ID: 36039035
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    O'Shea PM; O'Donoghue D; Bashari W; Senanayake R; Joyce MB; Powlson AS; Browne D; O'Sullivan GJ; Cheow H; Mendichovszky I; Quill D; Lowery A; Lappin D; Gurnell M; Dennedy MC
    Clin Endocrinol (Oxf); 2019 May; 90(5):670-679. PubMed ID: 30721535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional imaging with 11C-metomidate PET for subtype diagnosis in primary aldosteronism.
    Soinio M; Luukkonen AK; Seppänen M; Kemppainen J; Seppänen J; Pienimäki JP; Leijon H; Vesterinen T; Arola J; Lantto E; Helin S; Tikkanen I; Metso S; Mirtti T; Heiskanen I; Norvio L; Tiikkainen M; Tikkanen T; Sane T; Välimäki M; Gomez-Sanchez CE; Pörsti I; Nuutila P; Nevalainen PI; Matikainen N
    Eur J Endocrinol; 2020 Dec; 183(6):539-550. PubMed ID: 33055298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 11C-metomidate positron emission tomography after dexamethasone suppression for detection of small adrenocortical adenomas in primary aldosteronism.
    Hennings J; Sundin A; Hägg A; Hellman P
    Langenbecks Arch Surg; 2010 Sep; 395(7):963-7. PubMed ID: 20644954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate.
    Zettinig G; Mitterhauser M; Wadsak W; Becherer A; Pirich C; Vierhapper H; Niederle B; Dudczak R; Kletter K
    Eur J Nucl Med Mol Imaging; 2004 Sep; 31(9):1224-30. PubMed ID: 15197504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Para-chloro-2-[
    Silins I; Sundin A; Nordeman P; Jahan M; Estrada S; Monazzam A; Lubberink M; Aigbirhio F; Hellman P; Antoni G
    Int J Med Sci; 2021; 18(10):2187-2196. PubMed ID: 33859526
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomas.
    Burton TJ; Mackenzie IS; Balan K; Koo B; Bird N; Soloviev DV; Azizan EA; Aigbirhio F; Gurnell M; Brown MJ
    J Clin Endocrinol Metab; 2012 Jan; 97(1):100-9. PubMed ID: 22112805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [11C]metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings.
    Hennings J; Lindhe O; Bergström M; Långström B; Sundin A; Hellman P
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1410-4. PubMed ID: 16403816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computed tomography, magnetic resonance imaging and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas.
    Hennings J; Hellman P; Ahlström H; Sundin A
    Eur J Radiol; 2009 Feb; 69(2):314-23. PubMed ID: 18082990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of ¹⁸F-fluorodeoxyglucose PET/CT for transarterial chemolipiodolization of hepatocellular carcinoma.
    Song MJ; Bae SH; Yoo IeR; Park CH; Jang JW; Chun HJ; Choi BG; Lee HG; Choi JY; Yoon SK
    World J Gastroenterol; 2012 Jul; 18(25):3215-22. PubMed ID: 22783045
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Chen Cardenas SM; Santhanam P
    Endocrine; 2020 Dec; 70(3):479-487. PubMed ID: 32886316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [
    Wu X; Senanayake R; Goodchild E; Bashari WA; Salsbury J; Cabrera CP; Argentesi G; O'Toole SM; Matson M; Koo B; Parvanta L; Hilliard N; Kosmoliaptsis V; Marker A; Berney DM; Tan W; Foo R; Mein CA; Wozniak E; Savage E; Sahdev A; Bird N; Laycock K; Boros I; Hader S; Warnes V; Gillett D; Dawnay A; Adeyeye E; Prete A; Taylor AE; Arlt W; Bhuva AN; Aigbirhio F; Manisty C; McIntosh A; McConnachie A; Cruickshank JK; Cheow H; Gurnell M; Drake WM; Brown MJ
    Nat Med; 2023 Jan; 29(1):190-202. PubMed ID: 36646800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear imaging in the diagnosis of primary aldosteronism.
    Powlson AS; Gurnell M; Brown MJ
    Curr Opin Endocrinol Diabetes Obes; 2015 Jun; 22(3):150-6. PubMed ID: 25871964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of semiquantification NP-59 SPECT/CT in primary aldosteronism patients after adrenalectomy.
    Lu CC; Wu VC; Wu KD; Liu KL; Lin WC; Cheng MF; Tzen KY; Yen RF;
    Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1375-84. PubMed ID: 24525587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-in-human evaluation of [
    Silins I; Sundin A; Lubberink M; O'Sullivan L; Gurnell M; Aigbirhio F; Brown M; Wall A; Åkerström T; Roslin S; Hellman P; Antoni G
    Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):398-409. PubMed ID: 36074157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG.
    Minn H; Salonen A; Friberg J; Roivainen A; Viljanen T; Långsjö J; Salmi J; Välimäki M; Någren K; Nuutila P
    J Nucl Med; 2004 Jun; 45(6):972-9. PubMed ID: 15181132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
    Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
    Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role for Nuclear Medicine in diagnosis and management of patients with primary aldosteronism?
    Spyridonidis TJ; Apostolopoulos DJ
    Hell J Nucl Med; 2013; 16(2):134-9. PubMed ID: 23865085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased 18F-FDG Uptake on PET/CT is Associated With Poor Arterial and Portal Perfusion on Multiphase CT.
    Hwang SH; Lee M; Lee N; Park S; Kim CK; Park MA; Yun M
    Clin Nucl Med; 2016 Apr; 41(4):296-301. PubMed ID: 26756099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.